Degarelix Versus Leuprolide in Patients With Prostate Cancer: Effect in Metastatic Patients As Assessed By Serum Alkaline Phosphatase

DIAL.pr - BOREAL

Primary tabs

Authors	:	Schroder, F. H. Tombal, Bertrand [UCL] Boccon-Gibod, L. Miller, K. Jensen, J. K. Olesen, T. K. Persson, B-E et al.[show all]
Document type	:	Communication à un colloque (Conference Paper) – Abstract, Présentation orale avec comité de sélection
Access type	:	Accès restreint
Publication date	:	2009
Language	:	Anglais
Journal information	:	"European Urology Supplements" - Vol. 8, no. 4, p. 130-130 (2009)
Peer reviewed	:	yes
issn	:	1569-9056
Publisher	:	Elsevier Science Bv (Amsterdam)
Affiliations	:	UCL - Cliniques universitaires Saint-Luc UCL - MD/FSIO - Département de physiologie et pharmacologie
Links	:	[DOI]https://doi.org/10.1016/S1569-9056(09)60048-8 [Handle]http://hdl.handle.net/2078.1/58947

Bibliographic reference	Schroder, F. H. ; Tombal, Bertrand ; Boccon-Gibod, L. ; Miller, K. ; Jensen, J. K. ; et. al. Degarelix Versus Leuprolide in Patients With Prostate Cancer: Effect in Metastatic Patients As Assessed By Serum Alkaline Phosphatase.In: European Urology Supplements, Vol. 8, no. 4, p. 130-130 (2009)
Permanent URL	http://hdl.handle.net/2078.1/58947